
==== Front
Mol Cancer
Mol Cancer
Molecular Cancer
1476-4598
BioMed Central London

2111
10.1186/s12943-024-02111-x
Correction
Correction: Identification of miPEP133 as a novel tumor-suppressor microprotein encoded by miR-34a pri-miRNA
Kang Min km1019@163.com

123
Tang Bo dr_sntangbo@163.com

14
Li Jixi 1
Zhou Ziyan 1
Liu Kang 1
Wang Rensheng 3
Jiang Ziyan 25
Bi Fangfang 26
Patrick David 2
Kim Dongin 7
Mitra Anirban K. 89
http://orcid.org/0000-0002-0522-9053
Yang-Hartwich Yang yang.yang@yale.edu

210
1 https://ror.org/030sc3x20 grid.412594.f The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530022 China
2 grid.47100.32 0000000419368710 Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, CT 06510 USA
3 https://ror.org/030sc3x20 grid.412594.f Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021 China
4 https://ror.org/030sc3x20 grid.412594.f Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021 China
5 https://ror.org/04py1g812 grid.412676.0 0000 0004 1799 0784 The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029 China
6 https://ror.org/0202bj006 grid.412467.2 0000 0004 1806 3501 Sheng Jing Hospital of China Medical University, Shenyang, Liaoning 110004 China
7 https://ror.org/02aqsxs83 grid.266900.b 0000 0004 0447 0018 Department of Pharmaceutical Sciences College of Pharmacy, University of Oklahoma, Oklahoma City, OK 73117 USA
8 https://ror.org/00g1d7b60 0000 0004 0440 0167 Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN 46202 USA
9 https://ror.org/02ets8c94 0000 0001 2296 1126 Indiana University School of Medicine-Bloomington, Bloomington, IN 47405 USA
10 https://ror.org/03j7sze86 grid.433818.5 0000 0004 0455 8431 Yale Cancer Center, New Haven, CT 06510 USA
12 9 2024
12 9 2024
2024
23 195© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
issue-copyright-statement© BioMed Central Ltd., part of Springer Nature 2024
==== Body
pmc Correction: Mol Cancer 19, 143 (2020)

10.1186/s12943-020-01248-9

Recently in a re-examination of our previously published paper [1], “Identification of miPEP133 as a novel tumor-suppressor microprotein encoded by miR-34a pri-miRNA” [Molecular Cancer 19, article number 143 (2020)], we found two errors.

The first error is that we presented the wrong primer sequences for GAPDH in the Supplemental Methods (in the Additional file 2). We mistakenly listed the primer sequences for human β-actin (ACTB) as for GAPDH. The correct primer sequences for GAPDH are 5′-AATGAAGGGGTCATTGATGG − 3′ and 5′-AAGGTGAAGGTCGGAGTCAA − 3′. These were used in this study. Please find the resized Additional file 2 in the attachment.

The other error is a misplaced western blot image for the loading control β-actin in Fig. 4e. We have identified the correct image for β-actin bands. The following is the corrected figure.

They are minor errors, and their correction does not affect the conclusion of this article, however, we sincerely apologize to the readers and editors for the inconvenience caused by our mistakes. We would like to ask for an opportunity to publish this correction.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Additional file 2. This section describes the details of experimental procedures and materials that are not described in the Method Section, including Supplemental methods and lists of primers, antibodies, and plasmids. 

The online version of the original article can be found at 10.1186/s12943-020-01248-9.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Kang M Tang B Li J Identification of miPEP133 as a novel tumor-suppressor microprotein encoded by miR-34a pri-miRNA Mol Cancer 2020 19 143 10.1186/s12943-020-01248-9 32928232
Kang M, Tang B, Li J, et al. Identification of miPEP133 as a novel tumor-suppressor microprotein encoded by miR-34a pri-miRNA. Mol Cancer. 2020;19:143. 10.1186/s12943-020-01248-9.32928232 10.1186/s12943-020-01248-9
